bgb-26808
Showing 1 - 1 of 1
Advanced Solid Tumor, Solid Tumor Trial (BGB-26808, Tislelizumab)
Not yet recruiting
- Advanced Solid Tumor
- Solid Tumor
- BGB-26808
- Tislelizumab
- (no location specified)
Aug 7, 2023